Supplemental material
Cell Cycle
Volume 18, 2019 - Issue 18
Open access
2,497
Views
3
CrossRef citations to date
0
Altmetric
Research Paper
The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors
Mahnoush Bahjata Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands;b Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The NetherlandsView further author information
, Guus de Wildea Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands;b Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands
https://orcid.org/0000-0002-0928-9977View further author information
Tijmen van Dama Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands;b Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The NetherlandsView further author information
, Chiel Maasa Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands;b Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The NetherlandsView further author information
, Timon Bloedjesa Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands;b Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The NetherlandsView further author information
, Richard J. Bendea Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands;b Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands
https://orcid.org/0000-0002-5173-3138View further author information
Carel J.M. van Noesela Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands;b Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands
https://orcid.org/0000-0001-7907-7390View further author information
Dieuwertje M. Luijksb Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands;c Department of Experimental Immunology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The NetherlandsView further author information
, Eric Elderingb Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands;c Department of Experimental Immunology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The NetherlandsView further author information
, Marie José Kerstenb Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands;d Department of Hematology, Amsterdam University Centers, location AMC, University of Amsterdam, Amsterdam, The NetherlandsView further author information
& Jeroen E.J. Guikemaa Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands;b Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-6894-3441View further author information
Pages 2307-2322
|
Received 16 Jan 2019, Accepted 07 Jul 2019, Published online: 26 Jul 2019
Related Research Data
The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.